《大行報告》里昂:中資壽險企業9月保費收入仍弱 首選財險(02328.HK)及友邦(01299.HK)
里昂發表研究報告指,中資壽險企業9月的保費收入仍然較弱,因爲該些企業於7月底後仍面臨產品轉換的困擾。該行對壽險銷售有較低預期,並對中國壽險公司保持謹慎態度。財險方面,繼續看好中國財險(02328.HK),雖然今年第三季受到颱風影響,但由於累積了超額準備,預期財險今年首九個月的綜合成本率約爲97%。該行的首選仍然是友邦保險(01299.HK)和財險,認爲在宏觀挑戰下,兩間公司均更具防禦性。
該行預計,行業新業務價值將在第三季實現高單位數至低十位數增長,但8至9月的勢頭顯示第四季表現疲弱。另外,中國人壽(02628.HK)等部分公司已將重點轉向準備明年的開門紅銷售活動,而中國太保(02601.HK)則不再強調開門紅銷售,並可能繼續推動今年第四季銷售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.